committees

Health

Alzheimer’s drug donanemab gets FDA advisory committee’s green light : Shots

An advisory committee to the Food and Drug Administration has recommended that the federal agency approve Alzheimer’s drug donanemab. Andrew…

Read More »
Back to top button